Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Rovira, C. Martin, A. Moreno, N. Toran, J. C. Ferreres, S. Gartner, I. De Mir, A. Torrent (Barcelona, Spain). Infant interstitial lung disease: Review of our experience. Eur Respir J 2010; 36: Suppl. 54, 2685

Member's Comments

No comment yet.

Related content which might interest you: Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015 Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Effects of limb training in symptomatic patients with interstitial lung disease of different severity and etiology: A pilot study Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2 Year: 2014 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline Source: International Congress 2015 – New insights into IIPs Year: 2015 Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases Source: International Congress 2016 – Orphan diseases II Year: 2016 Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study Source: International Congress 2014 – ILDs 3 Year: 2014 Review of care in patients dying of pulmonary fibrosis in a district general hospital Source: International Congress 2016 – Orphan diseases I Year: 2016 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Pathology of smoking-related lung disease: an overview Source: Annual Congress 2008 - Smoking-related lung disease: from emphysema to pulmonary fibrosis Year: 2008 Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch Source: International Congress 2014 – ILDs 2 Year: 2014 Development of the interstitial lung disease multidiciplinary team meeting 2005-2013 Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Live patient and partner survey on pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Clinical findings at initial presentation of IPF patients at a university hospital referral center Source: International Congress 2014 – ILDs 5 Year: 2014 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Clues in interstitial lung disease in children (chILD) Source: International Congress 2016 – Paediatric bronchology II Year: 2016